Skip to main content
⚗️

Atomwise

AI drug discovery platform that screens billions of virtual compounds in hours

Healthcare
Atomwise logo

Atomwise

AI drug discovery platform that screens billions of virtual compounds in hours

Atomwise uses deep learning to predict how small molecules will bind to disease-relevant proteins, enabling pharmaceutical researchers to screen billions of virtual drug candidates in hours instead of years. Its AtomNet technology has been applied to targets for cancer, Ebola, MS, and rare diseases in partnerships with over 300 academic and biopharma organizations. Atomwise-generated compounds have progressed into preclinical and clinical studies.

Key Features

  • Billion-compound virtual screening
  • Binding affinity prediction
  • AtomNet deep learning
  • Target identification
  • Partnership programs
  • Preclinical support
#drug-discovery#pharmaceutical#deep-learning#molecular-modeling#biotech

Get Started

Visit Atomwise
🟠
Paid
Paid subscription required

Quick Info

Category
Healthcare
Pricing
Paid

More Healthcare Tools